Prosecution Insights
Last updated: April 19, 2026

Examiner: MARTIN, PAUL C

Tech Center 1600 • Art Units: 1653 1657

This examiner grants 42% of resolved cases

Performance Statistics

42.1%
Allow Rate
-17.9% vs TC avg
875
Total Applications
+22.0%
Interview Lift
1270
Avg Prosecution Days
Based on 819 resolved cases, 2023–2026

Rejection Statute Breakdown

5.0%
§101 Eligibility
14.7%
§102 Novelty
44.0%
§103 Obviousness
22.5%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
17945126 Pretreatment Of Plasma For Spray Drying And Storage Non-Final OA Velico Medical, Inc.
17778765 IMMUNOMAGNETIC SEQUENTIAL ULTRAFILTRATION PLATFORM FOR ENRICHMENT AND PURIFICATION OF EXTRACELLULAR VESICLES FROM BIOFLUIDS Non-Final OA OHIO STATE INNOVATION FOUNDATION
17613994 CELL STORAGE AND TRANSPORTATION MEDIUM, SYSTEM, AND METHOD OF CELL AGGREGATES Final Rejection CORNING INCORPORATED
18181023 OPTIMIZATION OF FLUID POOLING Non-Final OA Fenwal, Inc.
17616427 IMAGING SAMPLE FOR MASS SPECTROMETER AND METHOD FOR PRODUCING SAME Non-Final OA ASAHI KASEI KABUSHIKI KAISHA
18112279 SYSTEMS AND METHODS FOR FABRICATING PHYSIOLOGICALLY RELEVANT IN VITRO VESSELS Non-Final OA The Texas A&M University System
17682418 CONTAINER FOR SEPARATING LIVE CELLS Non-Final OA TERUMO KABUSHIKI KAISHA
18027821 METHOD OF APPLYING FORCE TO ORGANISM AND DEVICE FOR APPLYING FORCE TO ORGANISM Non-Final OA NIKON CORPORATION
17226793 METHODS FOR TREATING AORTIC ANEURYSM DISEASE Final Rejection Yale University
17917831 STEM CELL CULTURING METHOD FOR PROMOTING INITIAL YIELD OF STEM CELLS Final Rejection SAMSUNG LIFE PUBLIC WELFARE FOUNDATION
16091641 Method for Determining Stage of Periodontal Disease Final Rejection ARKRAY, Inc.
16558488 HIGH POTENCY PANCREATIN PHARMACEUTICAL COMPOSITIONS Non-Final OA Allergan Pharmaceuticals International Limited
16056033 3-DIMENSIONAL CARDIAC FIBROBLAST DERIVED EXTRACELLULAR MATRIX Final Rejection Wisconsin Alumni Research Foundation
15101740 METHOD OF REPAIRING AN ANNULUS AND COLLAGEN GEL COMPOSITION Final Rejection CORNELL UNIVERSITY
17440568 METHOD FOR CULTURING HEPATIC EPITHELIOID TISSUE HAVING A STRUCTURE OF CONNECTIONS BETWEEN HEPATOCYTES AND BILE DUCT EPITHELIAL CELL Final Rejection SAPPORO MEDICAL UNIVERSITY
18317443 BIFIDOBACTERIA FOR REDUCING FOOD, ENERGY AND/OR FAT INTAKE Final Rejection Dupont Nutrition Biosciences Aps
18045126 DECELLULARIZED VASCULAR GRAFTS, METHODS, AND BENCH-TOP MODELS OF ATHEROSCLEROSIS Non-Final OA Wayne State University
16973929 Recombinant Protease Inhibitor-Containing Compositions, Methods for Producing Same and Uses Thereof Non-Final OA ORAMED LTD.
15779766 PROCESS FOR PRODUCING HIGH PURITY STEVIOL GLYCOSIDES Final Rejection PureCircle Sdn Bhd
18088068 LIQUID THROMBIN REAGENT Non-Final OA Instrumentation Laboratory Company
17786579 THRIPS CONTROL Final Rejection Protix B.V.
17923244 USE OF EXTRACELLULAR VESICLES AS IMMUNOPROPHILACTICS AND IMMUNOTHERAPEUTICS FOR LEISHMANIASIS Final Rejection YEDITEPE UNIVERSITESI
17628719 STANDARD ORGANOID PRODUCTION METHOD Final Rejection NEXT & BIO INC.
18262433 METHOD OF CHANGING CULTURE MEDIUM OF A CULTURE USING SPINFILTERS Non-Final OA REPAIRON GMBH
18260418 BLASTOCYST-LIKE CELL AGGREGATE AND METHODS Non-Final OA IMBA - INSTITUT FÜR MOLEKULARE BIOTECHNOLOGIE GMBH
17619895 CELL RECOVERY METHOD AND CELL CULTURE DEVICE Non-Final OA Sinfonia Technology Co., Ltd.
18029391 3D STRUCTURES FOR CELL GROWTH Non-Final OA ACADEMISCH ZIEKENHUIS MAASTRICHT
18028555 BASAL CULTURE MEDIUM DEVELOPMENT METHOD, BASAL CULTURE MEDIUM FORMULATION AND DEVELOPMENT, AND SYSTEM THEREOF Non-Final OA SHENZHEN TAILI BIOTECHNOLOGY CO., LTD.
17164693 EXTRACELLULAR VESICLES WITH ENHANCED POTENCY Final Rejection United Therapeutics Corporation
17936027 METHODS FOR PROCESSING AND ANALYZING CELL-DERIVED VESICLES Final Rejection MDimune Inc.

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month